Jane Huang - Net Worth and Insider Trading
Jane Huang Net Worth
The estimated net worth of Jane Huang is at least $31 Million dollars as of 2024-11-13. Jane Huang is the CMO, Hematology of BeiGene Ltd and owns about 160,055 shares of BeiGene Ltd (BGNE) stock worth over $31 Million. Jane Huang is also the President, CMO of Prelude Therapeutics Inc and owns about 24,220 shares of Prelude Therapeutics Inc (PRLD) stock worth over $27,853. Details can be seen in Jane Huang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jane Huang has not made any transactions after 2023-04-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jane Huang
Jane Huang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jane Huang owns 3 companies in total, including BeiGene Ltd (BGNE) , Protara Therapeutics Inc (TARA) , and Prelude Therapeutics Inc (PRLD) .
Click here to see the complete history of Jane Huang’s form 4 insider trades.
Insider Ownership Summary of Jane Huang
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BGNE | BeiGene Ltd | 2021-12-14 | CMO & Hematology |
| TARA | Protara Therapeutics Inc | 2021-06-09 | director |
| PRLD | Prelude Therapeutics Inc | 2023-04-06 | President & CMO |
Jane Huang Latest Holdings Summary
Jane Huang currently owns a total of 2 stocks. Among these stocks, Jane Huang owns 160,055 shares of BeiGene Ltd (BGNE) as of December 14, 2021, with a value of $31 Million and a weighting of 99.91%. Jane Huang also owns 24,220 shares of Prelude Therapeutics Inc (PRLD) as of April 6, 2023, with a value of $27,853 and a weighting of 0.09%.
Latest Holdings of Jane Huang
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BGNE | BeiGene Ltd | 2021-12-14 | 160,055 | 193.64 | 30,993,050 |
| PRLD | Prelude Therapeutics Inc | 2023-04-06 | 24,220 | 1.15 | 27,853 |
Holding Weightings of Jane Huang
Jane Huang Form 4 Trading Tracker
According to the SEC Form 4 filings, Jane Huang has made a total of 32 transactions in BeiGene Ltd (BGNE) over the past 5 years, including 0 buys and 32 sells. The most-recent trade in BeiGene Ltd is the sale of 1,500 shares on December 14, 2021, which brought Jane Huang around $417,210.
According to the SEC Form 4 filings, Jane Huang has made a total of 1 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Prelude Therapeutics Inc is the sale of 13,280 shares on April 6, 2023, which brought Jane Huang around $81,274.
Insider Trading History of Jane Huang
- 1
Jane Huang Trading Performance
Jane Huang Ownership Network
Ownership Network List of Jane Huang
Ownership Network Relation of Jane Huang
Jane Huang Owned Company Details
What does BeiGene Ltd do?
Who are the key executives at BeiGene Ltd?
Jane Huang is the CMO & Hematology of BeiGene Ltd. Other key executives at BeiGene Ltd include director & 10 percent owner & Chief Executive Office John Oyler , SVP & General Counsel Chan Henry Lee , and Global Head of R&D Lai Wang .
BeiGene Ltd (BGNE) Insider Trades Summary
Over the past 18 months, Jane Huang made no insider transaction in BeiGene Ltd (BGNE). Other recent insider transactions involving BeiGene Ltd (BGNE) include a net sale of 21,808 shares made by Xiaobin Wu , a net sale of 4,186 shares made by Julia Aijun Wang , and a net sale of 11,300 shares made by Lai Wang .
In summary, during the past 3 months, insiders sold 33,070 shares of BeiGene Ltd (BGNE) in total and bought 0 shares, with a net sale of 33,070 shares. During the past 18 months, 5,416,337 shares of BeiGene Ltd (BGNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 5,416,337 shares.
BeiGene Ltd (BGNE)'s detailed insider trading history can be found in Insider Trading Tracker table.
BeiGene Ltd Insider Transactions
Jane Huang Mailing Address
Above is the net worth, insider trading, and ownership report for Jane Huang. You might contact Jane Huang via mailing address: C/o Mourant Ozannes Corporate Services, 94 Solaris Avenue, Camana Bay, Grand Cayman E9 Ky1-1108.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
